Patents
Patents for C07C 313 - Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (5,772)
02/2006
02/14/2006CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
12/2005
12/29/2005US20050288486 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
12/21/2005CN1709865A High-optical-purity chiral beta-alkamine compound, preparing method and its use
12/21/2005CN1709864A Taxol and its analogue side chain synthesizing method
12/15/2005DE4439128B4 Verfahren zur Reinigung von Natriumformaldehydsulfoxylat A process for the purification of sodium formaldehyde sulfoxylate
12/07/2005CN1705639A Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
12/06/2005CA2096528C Retroviral protease inhibitors
11/2005
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/17/2005US20050256201 Phenethanolamine derivatives
11/15/2005CA2123860C New herbicides
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
10/2005
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050221413 Sulfenyl compound, labeling reagent, and method of analyzing peptide
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951955 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
09/2005
09/21/2005CN1219758C Process for preparing optical purity di-t-butyl thioester-sulfinate
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
08/2005
08/24/2005CN1659154A Method of preparing amine stereoisomers
08/24/2005CN1657521A Bibenzyl compound plagiochin E and its extraction separation method and application
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
08/10/2005EP1561747A2 Process for the preparation of sulfinates poor in extraneous salts
08/10/2005CN1214004C Process for producing arylsulfenyl halide
08/03/2005CN1213019C Sulfonamide and carboxamide derivatives and drugs containing same as active ingredient
08/02/2005US6924391 Antiinflammatory agents; antitumor agent
07/2005
07/28/2005WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/28/2005US20050165240 Chemical intermediates for production of sibutramine
07/28/2005CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/19/2005US6919379 Compounds useful in reflux disease
07/14/2005WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them
07/13/2005CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
07/13/2005CN1636974A Process for producing sulfinate with low content exogenous salt
06/2005
06/30/2005US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
06/29/2005EP1545485A2 Treatment of cns disorders with trans-4- (3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine
06/15/2005EP1539682A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
06/09/2005DE10355088A1 Production of sulfinate with low extraneous salt content, for use e.g. as reducing agent or radical source in polymerisation, involves reduction of dithionite salt with carbonyl compound or imine under alkaline conditions
05/2005
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/25/2005EP1533296A1 Sulfenyl compound, labeling reagent, and method of analyzing peptide
05/17/2005US6894189 Methods of preparing didesmethylsibutramine and other sibutramine derivatives
05/12/2005WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
04/2005
04/21/2005WO2005035591A1 Arylsulfinate salts in photoinitiator systems for polymerization reactions
04/21/2005WO2005035590A1 Arylsulfinate salts in initiator systems for polymeric reactions
04/21/2005WO2005034885A1 Photoinitiators having triarylsulfonium and arylsulfinate ions
04/14/2005US20050079587 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation
04/07/2005US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals
03/2005
03/31/2005US20050070624 Arylsulfinate salts in photoinitiator systems for polymerization reactions
03/31/2005US20050070622 Arylsulfinate salts in initiator systems for polymeric reactions
03/31/2005US20050070621 sulfur compounds that generate free radical upon exposure to actinic radiation, for use as activators for addition polymerization reactions; photopolymerization
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/08/2005US6864392 α-Sulfin and α-Sulfonamino amide derivatives
02/2005
02/09/2005CN1188392C Process for synthesis of hydrocarbonfluoride
02/08/2005CA2096408C Retroviral protease inhibitors
02/02/2005CN1187346C Cyanothiophenyl balogen and preparation of 3-substituted benzoisothiazole therefrom
01/2005
01/25/2005US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/19/2005EP1497272A2 Method of preparing amine stereoisomers
01/19/2005EP1497268A2 Nitric oxide donors, compositions and methods of use
01/19/2005EP1497261A1 Phenethanolamine derivatives
01/13/2005US20050009816 Potassium channel modulators
01/05/2005CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
01/05/2005CN1183106C Industrial process for prodn. of diphenyl sulfone compounds
12/2004
12/14/2004US6831199 Pyrimidine compounds and derivatives thereof
12/08/2004EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/01/2004EP1425311A4 Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
11/2004
11/18/2004US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/02/2004US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
10/2004
10/13/2004EP1465863A1 Potassium channel modulators
09/2004
09/16/2004WO2003091207A3 Method of preparing amine stereoisomers
09/14/2004US6790866 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
09/08/2004EP1453777A1 Functionalized higher diamondoids
09/01/2004CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
08/2004
08/26/2004WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
08/18/2004EP1447397A1 Polyfunctional sulfonamides and sulfonates and process for preparing them
08/12/2004WO2004026814A3 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
08/05/2004US20040152775 Using a compound containing a amine and a sulfinate group; gastrointestinal disorders
08/03/2004US6770776 Synthesis of fluorocarbon compounds
07/2004
07/21/2004CN1514825A New compounds useful in reflux disease
07/15/2004WO2004024130A3 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE
07/14/2004EP1435964A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
07/14/2004EP1282595B1 Novel phenyl-propargylether derivatives
07/14/2004CN1157367C Method for prepn. of diacyl-chloride
07/08/2004US20040131544 Positron emission tomography ; multistage process; medical diagnosis
06/2004
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004US20040116617 Polymer-supported arylbis(perfluoroalkylsulfonyl)-methane
06/09/2004EP1425311A2 Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
05/2004
05/13/2004US20040092401 Plant safening agents
05/12/2004CN1496372A High polymer-supported arylbis(perfluoroalkylsulfonyl)-methane
05/06/2004US20040087661 Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
05/06/2004US20040087660 Methods of preparing didesmethylsibutramine and other sibutramine derivatives
05/04/2004US6730132 Reduction clearing of polyester textiles
04/2004
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/28/2004CN1147294C Pentafluorobenzenesulfonamides and analogs
04/21/2004EP1409516A2 Aromatic sulfenates for type i phototherapy
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/07/2004EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
04/01/2004WO2004026814A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
04/01/2004WO2002055562A3 Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
04/01/2004US20040063904 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
04/01/2004CA2498759A1 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
03/2004
03/25/2004WO2004024130A2 TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 58